ARTICLE | Clinical News
Rexahn preclinical data
November 22, 2010 8:00 AM UTC
In vitro, a fluoro quinoxalinyl-piperazine derivative inhibited the growth of various cancer cells with IC50 values ranging from 11-21 nM. Additionally, the compound was 70 times more effective than p...